Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
67,195.84 +1,389.31 (+2.11%) CMC Crypto 200
1,373.84 -0.01 (-0.00%)
Fulcrum Therapeutics, Inc. (FULC)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 11:52AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 484.49M |
| Enterprise value | 281.31M |
| Trailing P/E | 315.25 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 192.16 |
| Price/book (mrq) | 2.27 |
| Enterprise value/revenue | 112.08 |
| Enterprise value/EBITDA | -10.84 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.35 |
| 52-week change 3 | 139.85% |
| S&P500 52-week change 3 | 26.36% |
| 52-week high 3 | 13.70 |
| 52-week low 3 | 2.65 |
| 50-day moving average 3 | 8.57 |
| 200-day moving average 3 | 6.42 |
Share statistics
| Avg vol (3-month) 3 | 627.82k |
| Avg vol (10-day) 3 | 626.2k |
| Shares outstanding 5 | 62.15M |
| Implied shares outstanding 6 | 65.78M |
| Float 8 | 38.53M |
| % held by insiders 1 | 1.38% |
| % held by institutions 1 | 99.76% |
| Shares short (30 Apr 2024) 4 | 3M |
| Short ratio (30 Apr 2024) 4 | 6.41 |
| Short % of float (30 Apr 2024) 4 | 6.01% |
| Short % of shares outstanding (30 Apr 2024) 4 | 4.82% |
| Shares short (prior month 28 Mar 2024) 4 | 2.26M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -3,213.78% |
Management effectiveness
| Return on assets (ttm) | -28.56% |
| Return on equity (ttm) | -44.84% |
Income statement
| Revenue (ttm) | 2.81M |
| Revenue per share (ttm) | 0.05 |
| Quarterly revenue growth (yoy) | 27.20% |
| Gross profit (ttm) | N/A |
| EBITDA | -108.49M |
| Net income avi to common (ttm) | -97.33M |
| Diluted EPS (ttm) | -1.59 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 236.22M |
| Total cash per share (mrq) | 3.81 |
| Total debt (mrq) | 10.82M |
| Total debt/equity (mrq) | 4.60% |
| Current ratio (mrq) | 17.71 |
| Book value per share (mrq) | 3.80 |
Cash flow statement
| Operating cash flow (ttm) | -90.97M |
| Levered free cash flow (ttm) | -56.72M |
© 2024 Yahoo. All rights reserved.